We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TFII:TSXTFI International Inc. Analysis

Data as of 2026-05-28 - not real-time

CA$209.32

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

TFI International is trading at a price well above its discounted cash‑flow estimate, indicating significant overvaluation despite a bullish technical backdrop. The stock sits above its short‑term and intermediate moving averages, the RSI is in the upper range, and the MACD histogram remains positive, all pointing to strong momentum. However, recent earnings showed modest declines in revenue and net income, though management provided encouraging guidance and emphasized returning excess free cash flow to shareholders, which has rekindled analyst optimism.
Given the elevated price relative to fundamentals, a cautious approach is warranted. The dividend payout ratio is moderate and supported by solid operating cash flow, suggesting sustainability, while the company’s high beta and 30‑day volatility signal heightened price swings. Investors should weigh the near‑term upside from momentum against the long‑term risk of a price correction toward intrinsic value.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 8/10

Key Factors

  • Strong bullish technical indicators may be pricing in already‑run momentum
  • Current market price far exceeds DCF fair value
  • High short‑term volatility and beta increase downside risk

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Management guidance and capital‑return strategy support earnings stability
  • Dividend yield provides modest income while cash flow remains healthy
  • Valuation still premium but potential for price stabilization

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • Fundamental growth prospects in North‑American logistics
  • Sustainable dividend and solid free cash flow generation
  • Potential correction toward intrinsic value offering upside

Key Metrics & Analysis

Financial Health

Revenue Growth-0.80%
Profit Margin3.79%
P/E Ratio42.3
ROE11.26%
ROA4.60%
Debt/Equity119.57
P/B Ratio4.6
Op. Cash FlowCA$905.7M
Free Cash FlowCA$576.7M
Industry P/E30.1

Technical Analysis

TrendBullish
RSI71.5
SupportCA$181.76
ResistanceCA$213.12
MA 20CA$195.17
MA 50CA$177.06
MA 200CA$147.90
MACDBullish
VolumeDecreasing
Fear & Greed Index93.02

Valuation

Fair ValueCA$55.77
Target PriceCA$197.82
Upside/Downside-5.50%
GradeOvervalued
TypeGrowth
Dividend Yield1.22%

Risk Assessment

Beta1.24
Volatility37.70%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.